Waist–hip ratio and breast cancer risk in urbanized Nigerian women

bcr567 BCJ Research article Waist–hip ratio and breast cancer risk in urbanized Nigerian women Adebamowo A Clement clement.adebamowo@ channing.harvard.edu Ogundiran O Temidayo Adenipekun A Adeniyi Oyesegun A Rasheed Campbell B Oladapo Akang E Effiong Rotimi N Charles Olopade I Olunfunmilayo

Division of Oncology, Department of Surgery, University College Hospital, Ibadan, Nigeria

Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA

Radiotherapy Department, University College Hospital, Ibadan, Nigeria

Department of Pathology, University College Hospital, Ibadan, Nigeria

National Human Genome Center, Howard University, Washington DC, USA

Section of Hematology/Oncology, Department of Medicine, University of Chicago Pritzker School of Medicine, Chicago, Illinois, USA

Breast Cancer Res 1465-5411 2003 5 2 R18 R24 http://breast-cancer-research.com/content/5/2/R18 10.1186/bcr567 12631394 12 8 2002 10 10 2002 5 12 2002 19 12 2002 2003 Adebamowo et al., licensee BioMed Central Ltd. This article is published in Open Access:verbatim copying and redistribution of this article are permitted in all media for any non-commercial purpose, provided this notice is preserved along with the article's original URL. breast cancer Nigeria obesity waist–hip ratio women

Abstract

Background

The aim of this study was to examine the relationship between waist–hip ratio and the risk of breast cancer in an urban Nigerian population.

Methods

Between March 1998 and August 2000, we conducted a case–control study of hospital-based breast cancer patients (n = 234) and population-based controls (n = 273) using nurse interviewers in urban Southwestern Nigeria.

Results

Multivariable logistic regression showed a significant association between the highest tertile of waist–hip ratio and the risk of breast cancer (odds ratio= 2.67, 95% confidence interval = 1.05–6.80) among postmenopausal women. No association was found in premenopausal women.

Conclusion

The present study, the first in an indigenous African population, supports other studies that have shown a positive association between obesity and breast cancer risk among postmenopausal women.

Introduction

Breast cancer is the leading female malignancy in the world and is now the most common cancer in Nigeria 123. Despite this, there is a sixfold variation in incidence when Western countries are compared with the developing countries of Africa and Asia, and immigrants from low incidence countries tend to acquire the rate of their new environments 24. Some of this variation may be due to demographic factors such as longer life expectancy, better reporting of disease and improved access to clinical care. There is increasing interest, however, in the relative importance of environmental and genetic factors as explanations for this difference.

In general, African breast cancer patients tend to present at a young age, with large tumors and multiple nodal involvements, and have poorer clinical and pathological prognostic factors compared with Caucasian patients. These characteristics are somewhat similar to that of African-Americans but are in contrast with those of non-Hispanic Whites in the USA, thus heightening the interest in the role of genetic factors in the etiology of breast cancer in general, and in people of African origin in particular 35.

One of the often cited reasons for the difference in breast cancer incidence in Africa compared with Western countries is the difference in environmental risk factors such as diet and physical activity (both contributing to obesity), use of hormones/other medications, and obstetric/gynecological practices 6. In the current paper, we present the results of the first study of the association between waist–hip ratio (WHR) and breast cancer in an indigenous African population.

The WHR has emerged as an important metameter of the association between central adiposity and many obesity-related diseases. Positive correlations have been seen with coronary heart disease, adult-onset diabetes mellitus and stroke 7. However, the result with breast cancer has been inconsistent 8. Abdominal obesity may be related to breast cancer through aberrant insulin signaling leading to increased endogenous androgen and estrogen levels 9.

Methods

Case ascertainment

All consecutive cases of breast cancer, regardless of previous history, seen at presentation and later confirmed histologically in the Departments of Surgery and Radiotherapy of the University College Hospital, Ibadan, Nigeria, from March 1998 to August 2000 were recruited at their first clinic presentation, after obtaining informed consent. Nurse interviewers asked them which risk factors did apply at the time when they were last well. The interviewer then measured the height, weight, and hip circumference at its widest diameter. Waist circumference was measured according to the guidelines in the World Health Organization MONICA Project manual 10.

There were 312 cases, of which 73 indicated that they had lived predominantly in a rural area and were excluded. There were five refusals and no further information was available from these, leaving 234 cases.

Control ascertainment

During the period of case recruitment, a community adjoining the hospital was randomly selected by ballot based on comparability with the hypothetical catchment area of the hospital. Community consent was sought from the Chief-in-Council and approval for the study was communicated to members of the community through heads of households. The census register of the people living in the community was obtained and community consent sought for the study. Names were then randomly selected from the community register and the people were invited to visit a clinic set up in the community for the study.

Inclusion criteria for the controls were females aged older than 18 years, absence of any type of cancer at recruitment, predominant urban residence for most of their lives and the ability to give informed consent. No matching of controls to cases was performed. After explaining the project to the potential participant, a complete physical examination was carried out. A trained nurse then interviewed the participants, measured their height, their weight, their hip circumference at its widest diameter and their waist circumference 1 inch below the navel, and completed the questionnaires. A total of 278 subjects were interviewed, of which 273 were recruited; there were three refusals, and two people were not recruited on account of a diagnosis of cancer (head of the pancreas cancer in one and colorectal cancer in the other).

Data collection and analysis

The information obtained from the cases and controls include age, self-reported social status based on family income and other baseline demographic information. Obstetric and gynecological history such as age of onset of menarche, menstrual cycle history, whether periods had usually been regular, age at onset of menopause (natural or otherwise) and history of previous breast disease, as well as smoking, drug and alcohol use history, were obtained from the subjects. Other information obtained included first-degree family history of breast cancer, history of ever using estrogen-containing contraceptives and where they had lived most of their lives (whether in a rural or urban setting). No information about postmenopausal hormonal use was obtained as this is an uncommon practice in Nigeria.

The body mass index (BMI) (weight [kg]/height [m²]; obesity = BMI ≥ 30) and WHR were computed (waist circumference [cm]/hip circumference [cm]), and four subjects with WHR > 1.2 and WHR < 0.6 were excluded. The rest were divided into tertiles and treated as categories. Statistical analysis of the data was carried out with SAS version8.0 (SAS Institute, Inc., Cary, NC, USA) separately for premenopausal and postmenopausal women. Univariate analysis was used to identify variables to be included in multivariable analysis using P ≤ 0.10. Purposeful stepwise multivariable logistic regression models were built to identify statistically significant variables at P = 0.05, and a 10% or greater change in the β-coefficient was used to identify confounders. In addition, automated stepwise multivariate logistic regression models were run as an adjunct to the aforementioned method.

Continuous variables were examined for assumption of linearity; age and age at onset of regular menstrual periods were found to be nonlinear. Age was subsequently divided into 5-year categories while age at onset of regular menstrual periods was left as it was because the range of values was narrow, but it was subsequently modeled as a categorical variable.

Results

The WHR in this study was measured at presentation in cases and, since most patients presented in an advanced stage of disease, there may have been significant weight loss among the cases prior to recruitment. However, there was no significant difference in the frequency of the stage of disease (based on size of tumor at presentation) by obesity (BMI > 30) among premenopausal (P [chi-squared test] = 0.18) and postmenopausal women (P = 0.20) on the one hand, and in WHR among premenopausal women (P = 0.26) and postmenopausal women (P = 0.63) on the other.

Premenopausal women

Tables 1 and 2 present the results of age-adjusted analysis. Increasing age and age at first full-term pregnancy were positively associated with risk of breast cancer, while increasing age at onset of menarche was protective. Overall, categories of WHR were not significantly associated with the risk of breast cancer but there was a marginally significant test of trend for a positive association between increasing WHR and breast cancer risk. There was no association with total number of pregnancies, height, obesity (BMI ≥ 30) weight, BMI, waist and hip circumferences, family history of breast cancer, having ever breastfed and use of oral contraceptives. In multivariable logistic regression analysis, adjusted for age, age at menarche, age at first pregnancy and height, there was no significant association between the WHR and breast cancer risk (Table 3).

Table 1

Continuous predictors of breast cancer among premenopausal women in Nigeria, 1998–2000

Predictor

Cases

Controls

Odds ratio

95%confidence interval

P value

Age (years)

38.34 (6.55)

34.23 (8.80)

1.07

1.04–1.10

<0.01

Total number of pregnancies

4.41 (2.29)

3.82 (2.69)

0.90

0.79–1.03

0.13

Age at menarche (years)

15.01 (1.88)

15.51 (2.30)

0.86

0.77–0.97

0.01

Age at first full-term pregnancy (years)

23.80 (4.30)

22.54 (3.70)

1.09

1.02–1.16

0.01

Height (cm)

160.50 (8.62)

159.38 (7.17)

1.03

1.00–1.07

0.07

Weight (kg)

64.25 (14.51)

65.52 (15.28)

1.01

0.99–1.03

0.19

Body mass index (weight/height²)

24.76 (5.55)

23.65 (4.85)

1.02

0.97–1.07

0.54

Waist circumference (cm)

80.60 (11.84)

77.56 (10.73)

1.01

0.99–1.04

0.28

Hip circumference (cm)

99.03 (14.89)

97.07 (11.07)

1.01

0.99–1.02

0.61

Data presented as mean (standard deviation), age-adjusted odds ratio, 95% confidence interval, and P value for cases and controls.

Table 2

Categorical predictors of breast cancer among premenopausal women in Nigeria, 1998–2000

Predictor

Cases

Controls

Odds ratio

95%confidence interval

P value

Waist–hip ratio

≤ 0.77

37 (30.8)

64 (35.6)

1.00

>0.77 to ≤ 0.85

45 (37.5)

78 (43.3)

0.88

0.50–1.55

0.65

>0.85

38 (31.67)

38 (21.2)

1.41

0.80–2.78

0.22

Family history of breast cancer

Yes

11 (9.17)

14 (7.78)

1.37

0.58–3.22

0.48

109 (90.83)

166 (92.22)

Obesity (body mass index ≥ 30)

Yes

29 (24.17)

25 (13.89)

1.52

0.82–2.82

0.18

91 (75.83)

155 (86.11)

Having ever breastfed

Yes

102 (85.71)

133 (73.89)

1.04

0.50–2.18

0.91

17 (14.29)

47 (26.11)

Use of contraceptive pill

Yes

53 (45.30)

62 (34.44)

0.84

0.51–1.39

0.50

64 (54.70)

118 (65.56)

Social status

Low

54 (46.15)

98 (54. 75)

1.00

0.15

Middle

60 (51.28)

80 (44.69)

1.36

0.85–2.18

High

3 (2.56)

1 (0.56)

5.44

0.55–53.62

Data presented as number (%), age-adjusted odds ratio, 95% confidence interval, and P value for cases and controls.

Table 3

Multivariable odds ratio, 95% confidence interval andP value, adjusted for age in categories, age at first pregnancy, height and age at menarche in premenopausal women in Nigeria, 1998–2000

Predictor

Adjusted odds ratio

95%confidence interval

P value

Waist–hip ratio

≤ 0.77

1.00

>0.77 to ≤ 0.85

0.80

0.40–1.60

0.53

>0.85

1.80

0.85–3.81

0.13

Postmenopausal women

On the other hand, in age-adjusted logistic regression models among postmenopausal women (Tables 4 and 5), increasing age was associated with a reduced breast cancer risk, while increasing height, waist circumference and obesity (BMI ≥ 30) were positively associated with breast cancer risk. There was a significant association with the highest tertile of WHR but the likelihood ratio test (LRT) for trend (P = 0.07) was not significant. The association with having ever breastfed could not be ascertained because of an inadequate sample size. In multivariable logistic regression analysis, adjusted for age and height, there was a significant association between the highest tertile of WHR and breast cancer risk (LRT P = 0.10; Table 6).

Table 4

Continuous predictors of breast cancer among postmenopausal women in Nigeria, 1998–2000

Predictor

Cases

Controls

Odds ratio

95%confidence interval

P value

Age (years)

53.62 (9.55)

58.42 (7.92)

0.939

0.09–0.97

0.01

Total number of pregnancies

5.99 (2.21)

6.75 (2.24)

0.89

0.71–1.02

0.10

Age at menarche (years)

15.58 (2.11)

16.35 (2.72)

0.89

0.78–1.02

0.08

Age at first full-term pregnancy (years)

23.34 (4.23)

22.99 (4.20)

0.98

0.92–1.06

0.65

Age at onset of natural menopause (years)

47.37 (6.49)

50.02 (5.59)

0.97

0.91–1.03

0.35

Height (cm)

159.37 (6.66)

155.99 (9.33)

1.07

1.02–1.13

0.01

Weight (kg)

65.52 (15.28)

62.32 (13.66)

1.02

1.00–1.04

0.07

Body mass index (weight/height²)

25.71 (5.86)

25.39 (5.63)

1.02

0.97–1.08

0.48

Waist (cm)

86.11 (14.18)

83.28 (10.36)

1.01

1.00–1.05

0.03

Hip (cm)

102.31 (17.05)

102.88 (16.93)

1.00

0.98–1.02

0.93

Data presented as mean (standard deviation), age-adjusted odds ratio, 95% confidence interval, and P value for cases and controls.

Table 5

Comparison of categorical predictors of breast cancer among postmenopausal women in Nigeria, 1998–2000

Predictor

Cases

Controls

Odds ratio

95%confidence interval

P value

Waist–hip ratio

≤ 0.77

16 (15.4)

21 (23.6)

1.00

>0.77 to ≤ 0.85

40 (38.5)

40 (44.9)

1.52

0.67–3.42

0.31

>0.85

48 (46.15)

28 (31.5)

2.79

1.21–6.45

0.02

Family history of breast cancer

Yes

7 (6.73)

8 (8.99)

0.70

0.23–2.09

0.52

97 (93.27)

81 (91.01)

Obesity

Yes

31 (29.81)

16 (17.98)

2.01

0.99–4.09

0.05

73 (70.19)

73 (82.02)

Having ever breastfed

Yes

101 (97.12)

89 (100)

3 (2.88)

0 (0)

Use of contraceptive pill

Yes

34 (34)

25 (28.09)

0.96

0.50–1.84

0.90

66 (66)

64 (71.91)

Social status

Low

49 (47.12)

57 (64.77)

1.00

0.97–3.19

0.06

Middle

47 (45.19)

31 (35.23)

1.79

High

8 (7.69)

Data presented as number (%), age-adjusted odds ratio, 95% confidence interval, and P value for cases and controls. ^aValues could not be computed because of zero-cell.

Table 6

Multivariable odds ratio, 95% confidence interval and P value, adjusted for age in categories and height in postmenopausal women in Nigeria, 1998–2000

Predictor

Adjusted odds ratio

95% confidence interval

P value

Waist–hip ratio

≤ 0.77

1.00

>0.77 to ≤ 0.85

1.68

0.68–4.19

0.26

>0.85

2.67

1.05–6.80

0.04

Discussion

The earliest reports of the positive association between energy balance and breast cancer date back to 1942 11. Numerous case–control and cohort studies have subsequently supported this association. However, the strength of the association and the category of patients in whom the association was seen varied from study to study. In addition, there are methodological concerns about the most appropriate measure of obesity, and which component or type of obesity is etiologically significant.

The WHR, a measure of central adiposity, is gaining increased use as a measure of etiologically significant obesity and is thought to be more closely related to pathology, especially coronary heart disease, diabetes mellitus and stroke 7. The metabolic changes that accompany obesity include peripheral hyperinsulinemia, hyperglycemia and glucose intolerance, hypertriglyceridemia, decreased serum low-density lipoprotein, increased serum very low-density lipoprotein, increased serum leptin, dyslipidemia, increased serum cortisol clearance, increased serum C-peptide level, downregulation of insulin receptors and an exaggerated insulin response to an oral glucose load 12131415. These changes, especially when they occur in early adulthood, may be of fundamental importance in the development of breast cancer 916.

Obesity is also associated with significant hormonal changes such as decreased serum estradiol and sex hormone binding globulin (SHBG) levels, increased peripheral fat conversion of estrogens to progesterone and increased serum testosterone levels that may be associated with an increased risk of breast cancer 17. Estrogens are necessary for normal breast development, and they induce and promote mammary tumor growth in animal studies 18. In addition, the close association between increased risk of breast cancer and certain reproductive factors such as early menarche and late menopause 19, as well as the fall off in the rate of increase in the incidence of disease at menopause 20 and the lowered risk of breast cancer in oophorectomized women and those taking antiestrogens 2122, all support the role of estrogen in breast carcinogenesis.

The results from cohort studies about the association between WHR and the risk of breast cancer are inconsistent. In the Nurses' Health Study, the adjusted risk for the highest quintile compared with the lowest quintile of WHR among postmenopausal women who had never used hormone replacement therapy was 1.85 (95% confidence interval = 1.25–2.74) 23. Kaaks et al. reported a risk ratio of 2.63 (95% confidence interval = 1.09–6.35) comparing the highest quintile with the lowest quintile of WHR 24. These are similar to the results obtained in the present study. In contrast, the Iowa Women's Health Study showed no association with WHR, and an earlier report of interaction with family history appeared to have attenuated with time 2526. In the New York University Women's Health Study, the multivariable analysis showed an association between the lowest quintile and the highest quintile of WHR and breast cancer of 1.72 (95% confidence interval = 1.0–3.1) among premenopausal women, but there was no association among postmenopausal women 27.

Most case–control studies have found an association between WHR and the risk of postmenopausal breast cancer 28293031323334353637, and most report either null or weakly positive association with premenopausal breast cancer. In the present study, there was no statistically significant association between breast cancer and WHR for premenopausal women.

Studies of WHR and the risk of breast cancer are limited by systematic bias in the measurement of WHR across studies 36, which may have been controlled somewhat in this study by using nurse interviewers and adhering to the World Health Organization MONICA guidelines 10. In case–control studies like the present one, selection and recall bias can be problematic. While we restricted our analysis to urban dwellers, finer adjustment based on the community of residence or the restriction of cases to only those from the community from which controls were selected would have increased the validity of the result. The finding of two cases of cancer among the controls may be due to chance.

The prevalence of obesity in the cases and controls also appears higher than expected but this may be consistent with the increasing rate of obesity in developing countries, especially in the urban areas 38. Preclinical weight loss is not usually a problem in breast cancer 39, and sub-analysis of our data confirmed this. Inclusion of obesity in the multivariate analysis did not change the result, and obesity was not a significant predictor of outcome in multivariate regression analysis. Other limitations of this study include the absence of information about breastfeeding and the features of a 'Western lifestyle' such as physical activity, diet and use of postmenopausal hormones and other medications.

In conclusion, the present study is consistent with findings in other environments that central adiposity is a risk factor for breast cancer in postmenopausal women.

Competing interests

None declared.

Abbreviations

BMI = body mass index; LRT = likelihood ratio test; SHBG = sex hormone binding globulin; WHR = waist–hip ratio.

Acknowledgements

The authors thank Ms Funmi Oyetunji and Ms Fisayo Adejuyigbe for conducting the interviews. Supported in part through a generous grant from the Falk Medical Research Trust (to OIO). OIO is a Doris Duke Distinguished Clinical Scholar.

ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. McPherson K Steel CM Dixon JM BMJ 2000 321 624 628 10.1136/bmj.321.7261.624 10977847 Neoplasms of the breast. Fisher B Osborne KC Bloomer WD Margolese RG In Cancer Medicine Plus [CD-ROM] Baltimore, MD: Williams and Wilkins Holland JF, Frei III E, Bast RC, Morton DL, Kufe DW, Weichselbaum RR 1998 Breast cancer in Nigeria. Adebamowo CA Ajayi OO West Afr J Med 2000 19 179 191 11126081 Migration patterns and breast cancer risk in Asian-American women. Ziegler RG Hoover RN Pike MC Hildesheim A Nomura AM West DW Wu-Williams AH Kolonel LN Horn-Ross PL Rosen-thal JF J Natl Cancer Inst 1993 85 1819 1827 8230262 Tumor biology and prognosis in black breast cancer patients: a review. Rose DP Royak-Schaler R Cancer Detect Prev 2001 25 16 31 11270418 Review of anthropometric factors and breast cancer risk. Friedenreich CM Eur J Cancer Prev 2001 10 15 32 10.1097/00008469-200102000-00003 11263588 Human obesity: an evolutionary approach to understanding our bulging waistline. Lev-Ran A Diabetes Metab Res Rev 2001 17 347 362 10.1002/dmrr.230 11747140 Risk factors for breast cancer at young ages in twins: an international population-based study. Swerdlow AJ De Stavola BL Floderus B Holm NV Kaprio J Verkasalo PK Mack T J Natl Cancer Inst 2002 94 1238 1246 10.1093/jnci/94.16.1238 12189227 Upper abdominal obesity, insulin resistance and breast cancer risk. Stoll BA Int J Obes Relat Metab Disord 2002 26 747 753 10.1038/sj.ijo.0801998 12037643 WHO WHO MONICA Project Manual. Geneva: World Health Organization MONICA Project; 1990 Genesis and growth of tumors. II. Effects of caloric restriction per se. Tannenbaum A Cancer Res 1942 2 460 467 Mechanisms of insulin resistance in human obesity. Kolterman OG Insel J Saekow M Olefsky JM J Clin Invest 1980 65 1272 1284 6997333 Insulin and related factors in premenopausal breast cancer risk. Del Giudice ME Fantus IG Ezzat S McKeown-Eyssen G Page D Goodwin PJ Breast Cancer Res Treat 1998 47 111 120 10.1023/A:1005831013718 9497099 Is fasting insulin concentration inversely associated with rate of weight gain? Contrasting findings from CARDIA and ARIC study cohorts. Folsom AR Vitelli LL Lewis CE Schreiner PJ Watson RL Wagenknecht LE Int J Obes Relat Metab Disord 1998 22 48 54 10.1038/sj.ijo.0800542 9481599 Nutrition, hormones, and breast cancer: is insulin the missing link? Kaaks R Cancer Causes Control 1996 7 605 625 8932921 Endogenous estrogens and breast cancer risk: the case for prospective cohort studies. Toniolo PG Environ Health Perspect 1997 105 587 592 9168000 Insulin-like growth factor physiology and cancer risk. Pollack M Eur J Cancer 2000 36 1224 1228 10.1016/S0959-8049(00)00102-7 10882860 The production of mammary cancer in rats using oestrogens. Mackenzie I Br J Cancer 1955 9 284 299 13239956 Epidemiology and prevention of breast cancer. Kelsey JL Bernstein L Annu Rev Public Health 1996 17 47 67 10.1146/annurev.pu.17.050196.000403 8724215 The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Key TJ Pike MC Eur J Cancer Clin Oncol 1988 24 29 43 3276531 The relationship of cancer of the female breast to artificial menopause and marital status. Lilienfeld AM Cancer 1956 9 927 934 13364877 Tamoxifen for the primary prevention of breast cancer: a review and critique of the concept and trial. Bush TL Helzlsouer KJ Epidemiol Rev 1993 15 233 244 8405207 Waist circumference, waist:hip ratio, and risk of breast cancer in the Nurses' Health Study. Huang Z Willett WC Colditz GA Hunter DJ Manson JE Rosner B Speizer FE Hankinson SE Am J Epidemiol 1999 150 1316 1324 10604774 Breast-cancer incidence in relation to height, weight and body-fat distribution in the Dutch 'DOM' cohort. Kaaks R Van Noord PA Den Tonkelaar I Peeters PJ Riboli E Grobbee DE Int J Cancer 1998 76 647 651 10.1002/(SICI)1097-0215(19980529)76:5<647::AID-IJC6>3.0.CO;2-Q 9610720 Does body fat distribution promote familial aggregation of adult onset diabetes mellitus and postmenopausal breast cancer? Sellers TA Sprafka JM Gapstur SM Rich SS Potter JD Ross JA McGovern PG Nelson CL Folsom AR Epidemiology 1994 5 102 108 8117767 Interaction of waist/hip ratio and family history on the risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women. Sellers TA Davis J Cerhan JR Vierkant RA Olson JE Pankratz VS Potter JD Folsom AR Am J Epidemiol 2002 155 225 233 10.1093/aje/155.3.225 11821247 Body fat distribution and obesity in pre- and postmenopausal breast cancer. Sonnenschein E Toniolo P Terry MB Bruning PF Kato I Koenig KL Shore RE Int J Epidemiol 1999 28 1026 1031 10.1093/ije/28.6.1026 10661643 Body fat distribution and breast cancer in the Framingham Study. Ballard-Barbash R Schatzkin A Carter CL Kannel WB Kreger BE D'Agostino RB Splansky GL Anderson KM Helsel WE J Natl Cancer Inst 1990 82 286 290 2299677 Abdominal obesity and breast cancer risk. Schapira DV Kumar NB Lyman GH Cox CE Ann Intern Med 1990 112 182 186 2297194 Obesity and subcutaneous fat patterning in relation to breast cancer in postmenopausal women participating in the Diagnostic Investigation of Mammary Cancer Project. den Tonkelaar I Seidell JC Collette HJ de Waard F Cancer 1992 69 2663 2667 1571895 Body size and breast cancer risk among women under age 45 years. Swanson CA Coates RJ Schoenberg JB Malone KE Gammon MD Stanford JL Shorr IJ Potischman NA Brinton LA Am J Epidemiol 1996 143 698 706 8651232 Body measurements, estrogen availability and the risk of human breast cancer – a case–control study. Bruning PF Bonfrer JM Hart AA van Noord PA van der Hoeven H Collette HJ Battermann JJ de Jong-Bakker M Nooijen WJ de Waard F Int J Cancer 1992 51 14 19 1563834 Increased incidence of carcinoma of the breast assoicated with abdominal adiposity in postmenopausal women. Folsom AR Kaye SA Prineas RJ Potter JD Gapstur SM Wallace RB Am J Epidemiol 1990 131 794 803 2138863 Body size indicators and risk of breast cancer according to menopause and estrogen receptor status. Mannisto S Pietinen P Pyy M Cancer 1996 68 8 13 10.1002/(SICI)1097-0215(19960927)68:1<8::AID-IJC2>3.0.CO;2-V Is body fat topography a risk factor for breast cancer? Petrek JA Peters M Cirrincione C Rhodes D Bajorunas D Ann Intern Med 1993 118 356 362 8430981 Body size and breast cancer risk in black women and white women: the Carolina Breast Cancer Study. Hall IJ Newman B Millikan RC Moorman PG Am J Epidemiol 2000 151 754 764 10965972 Association of body size and fat distribution with risk of breast cancer among Chinese women. Shu XO Jin F Dai Q Shi JR Potter JD Brinton LA Hebert JR Ruan Z Gao YT Zheng W Int J Cancer 2001 94 449 455 10.1002/ijc.1487 11745429 World Health Organization Diet, Nutrition and the Prevention of Chronic Diseases. Geneva: World Health Organization; 2002 1 55 Prospective study of relative weight, height, and risk of breast cancer. London SJ Colditz GA Stampfer MJ Willett WC Rosner B Speizer FE JAMA 1989 262 2853 2858 10.1001/jama.262.20.2853 2810620